Official UK procurement notice
Qualified Person Certification of Advanced Therapy Medicinal Products
Authority: Guy's and St Thomas' NHS Foundation Trust (Central government)
Sectors: Research & Development (R&D) (73) Delivery: Delivery location not published
Awarded value£100,250published award · exc. VAT
Award in standstill Not publishedno call for competition
Award (standstill) to eXmoor Pharma Concepts Limited
What is being bought
Published requirement descriptionGuy’s and St Thomas’ NHS Foundation Trust requires a Qualified Person service to certify Advanced Therapy Medicinal Products for patients enrolled in clinical trials. The service will ensure compliance with the requirements of the MHRA licence and all applicable legal and regulatory obligations, enabling the certification and release of medicinal products for clinical use.
The lotProcurement structure
single lot · no lot value publishedLot #1Lot 1Awarded
73200000 Research and development consultancy services
Procedure terms & legal framework
From the official record- Procedure method
- Direct award
- Legal basis
- UKPGA · 2023/54 Procurement Act 2023
- Notice status
- Awarded without competition
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Direct award — no call for competition
- GPA / WTO covered
- Unspecified in notice
- Recurring procurement
- No (one-off requirement)
- First published
- 28 Sept 2026, 12:14 BST
- Last source update
- 28 Sept 2026, 12:14 BST
- Authority reference
C471451- Latest notice
- Transparency notice (UK5)
- Delivery area
- Not published
- Official registry OCID
ocds-h6vhtk-077b6e
- Why no open competition
- Single Suppliers Technical Reasons; Additional Repeat Extension Partial Replacement
- Published justification
The following rationale supports the proposed direct award under Schedule 5 of the Procurement Act 2023 on the grounds of technical reasons. Exmoor Pharma QP brings specialist expertise in advanced therapies medicinal products, together with direct and extensive familiarity with T-reg and CAR-T reg manufacturing. This combination of advanced therapy experience and product-specific knowledge is highly specialised and more…
is unlikely to be readily available from another QP. Such familiarity provides significant value in the assessment and oversight of manufacturing activities, deviations, investigations, quality decisions, and batch certification, where an understanding of the specific product, process and associated risks is essential. Retaining this expertise therefore provides both a regulatory and operational benefit. It supports continued GMP compliance while avoiding the potentially lengthy learning period associated with transferring responsibility to a new QP who has no prior experience of the organisation or T-reg manufacturing process. It also reduces the risk of disruption to manufacturing activities and the consequential impact on production capacity and patient supply. Guy’s and St Thomas’ NHS Foundation Trust is relying on Section 41 and Paragraph 6(a) and 7(b) of Schedule 5 of the Procurement Act 2023 to justify the use of direct award in special cases.
Commercial outcome & contract awards
Published awards, contracts and bid statistics — not a forecastAwards 1some still in standstill
Awarded value £100,2501 award exc. VAT
| Awarded to | Value | Date | Status |
|---|---|---|---|
| eXmoor Pharma Concepts LimitedSME12 Oct 2026 — 4 Oct 2031Options: Option to renew for a year up to 4 years depend on service quality, availability of funding and clinical needs. · Amended: The contract start date should be 12th of October 2026 | £100,250 | — | Standstill |
Notice history
3 events · 2 releases on Find a Tender · since 28 Sept 2026- Contract signature expected12 Oct 2026, 23:59 BSTscheduled
- Transparency notice published28 Sept 2026, 12:14 BSTUK5
- Transparency notice published28 Sept 2026, 12:09 BSTUK5
Contracting authority & participating public bodies
Bidders & participating suppliers
1 commercial party on the notice- eXmoor Pharma Concepts LimitedAwarded supplier
Official documents & specifications (3)
Official links; attachments are not copiedTender pack and attachments
- Conflict of interest declarationNot published
Notices published for this procedure
- Transparency notice Transparency notice on Find a Tender
- Transparency notice Transparency notice on Find a Tender